The ductus arteriosus: a refined approach!

Although ongoing patency of the ductus arteriosus is common in small extremely preterm infants, consensus is lacking regarding its clinical significance and treatment strategies. Literature regarding likelihood of spontaneous closure, impact on neonatal morbidity and long-term outcomes, and adverse effects of intervention has led to uncertainty as to the best course of action. Enhancing the determination of hemodynamic significance and refining patient selection for therapeutic intervention will streamline the decision-making process. Targeted neonatal echocardiography performed by the clinician has gained popularity worldwide, and preliminary data show that it has the potential to optimize patient outcomes. We review the arguments for and against medical and surgical therapy, explore how targeted neonatal echocardiography used in conjunction with biomarkers may refine the treatment approach, and consider future directions in the field.

[1]  P. McNamara,et al.  Indomethacin Impairs Coronary Perfusion in Infants with Hemodynamically Significant Ductus Arteriosus , 2011, Neonatology.

[2]  P. McNamara,et al.  The patent ductus arteriosus ligation decision. , 2011, The Journal of pediatrics.

[3]  P. McNamara,et al.  Point-of-care ultrasound in the neonatal intensive care unit: international perspectives. , 2011, Seminars in fetal & neonatal medicine.

[4]  P. McNamara,et al.  Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[5]  P. McNamara,et al.  Patent ductus arteriosus ligation and post-operative hemodynamic instability: Case report and framework for enhanced neonatal care , 2010, Indian journal of pediatrics.

[6]  P. McNamara,et al.  Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g. , 2010, The Journal of thoracic and cardiovascular surgery.

[7]  M. Molenschot,et al.  Is cerebral oxygen supply compromised in preterm infants undergoing surgical closure for patent ductus arteriosus? , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[8]  P. McNamara,et al.  Haemodynamic changes after delivery room surfactant administration to very low birth weight infants , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[9]  P. Wludyka,et al.  Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis , 2010, Journal of Perinatology.

[10]  W. Benitz.  Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? , 2010, Journal of Perinatology.

[11]  Marshall E. Smith,et al.  Should all newborns who undergo patent ductus arteriosus ligation be examined for vocal fold mobility? , 2009, The Laryngoscope.

[12]  T. Inder,et al.  Developmental and Neuropathological Consequences of Ductal Ligation in the Preterm Baboon , 2009, Pediatric Research.

[13]  K. Sekar,et al.  Failure of Ductus Arteriosus Closure Is Associated With Increased Mortality in Preterm Infants , 2009, Pediatrics.

[14]  E. Molloy,et al.  Influence of a patent ductus arteriosus on cardiac troponin T levels in preterm infants. , 2008, The Journal of pediatrics.

[15]  I. Seri,et al.  Echocardiography and the Neonatologist , 2008, Pediatric Cardiology.

[16]  P. McNamara,et al.  Does point-of-care functional echocardiography enhance cardiovascular care in the NICU? , 2008, Journal of Perinatology.

[17]  G. V. Arsdell,et al.  Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention , 2008, Journal of Perinatology.

[18]  E. Molloy,et al.  Patent ductus arteriosus evaluation by serial echocardiography in preterm infants , 2008, Acta paediatrica.

[19]  R. A. Sinkin,et al.  Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. , 2007, American journal of obstetrics and gynecology.

[20]  M. Laughon,et al.  Patent ductus arteriosus: lack of evidence for common treatments , 2007, Archives of Disease in Childhood Fetal and Neonatal Edition.

[21]  P. McNamara,et al.  Towards rational management of the patent ductus arteriosus: the need for disease staging , 2007, Archives of Disease in Childhood Fetal and Neonatal Edition.

[22]  O. Kamlin,et al.  Free-flow oxygen delivery using a T-piece resuscitator , 2007, Archives of Disease in Childhood Fetal and Neonatal Edition.

[23]  I. Seri,et al.  Changes in myocardial function and hemodynamics after ligation of the ductus arteriosus in preterm infants. , 2007, The Journal of pediatrics.

[24]  C. Leonard,et al.  Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity , 2007, Pediatrics.

[25]  L. Doyle,et al.  Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. , 2007, The Journal of pediatrics.

[26]  M. Laughon,et al.  Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes , 2007, Journal of Perinatology.

[27]  R. Clyman,et al.  Patent ductus arteriosus: evidence for and against treatment. , 2007, The Journal of pediatrics.

[28]  K. Nicolaides,et al.  Predictors of Neonatal Outcome in Early- Onset Placental Dysfunction , 2007, Obstetrics and gynecology.

[29]  Istvan Seri,et al.  Functional echocardiography: an emerging clinical tool for the neonatologist. , 2007, The Journal of pediatrics.

[30]  Yasuhiro Kawase,et al.  Gastrointestinal perforation in very low‐birthweight infants , 2006, Pediatrics international : official journal of the Japan Pediatric Society.

[31]  C. Ramaciotti,et al.  Prevalence of Spontaneous Closure of the Ductus Arteriosus in Neonates at a Birth Weight of 1000 Grams or Less , 2006, Pediatrics.

[32]  R. Clark,et al.  New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure , 2006, Journal of Perinatology.

[33]  G. Kongolo,et al.  Severity of the ductal shunt: a comparison of different markers , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[34]  J. Huhta,et al.  The Hemodynamic Effects of Neonatal Patent Ductus Arteriosus Shunting on Superior Mesenteric Artery Blood Flow , 2005, Journal of Perinatology.

[35]  A. Kaunitz,et al.  Assessing the Neonatal Safety of Indomethacin Tocolysis: A Systematic Review With Meta-Analysis , 2005, Obstetrics and gynecology.

[36]  D. Doherty,et al.  Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[37]  T. Yanowitz,et al.  Asymmetry of Cerebral Blood Flow Velocity in Low Birth Weight Infants , 2005, Neonatology.

[38]  B. Van Overmeire,et al.  The pharmacologic closure of the patent ductus arteriosus. , 2005, Seminars in fetal & neonatal medicine.

[39]  A. Lusky,et al.  Patent Ductus Arteriosus, Indomethacin and Necrotizing Enterocolitis in Very Low Birth Weight Infants: A Population-Based Study , 2005, Journal of pediatric gastroenterology and nutrition.

[40]  J. Rozé,et al.  Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[41]  J. Weyler,et al.  Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[42]  M. Laughon,et al.  Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? , 2004, Current opinion in pediatrics.

[43]  S. Nicolson,et al.  A comparison of on-site and off-site patent ductus arteriosus ligation in premature infants. , 2003, Pediatrics.

[44]  A. Leonhardt,et al.  Do we need another NSAID instead of indomethacin for treatment of ductus arteriosus in preterm infants? , 2003, Acta paediatrica.

[45]  S. Abbasi,et al.  Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study. , 2003, American journal of obstetrics and gynecology.

[46]  N. Evans.  CURRENT CONTROVERSIES IN THE DIAGNOSIS AND TREATMENT OF PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS , 2003, Advances in neonatal care : official journal of the National Association of Neonatal Nurses.

[47]  S. Chida,et al.  Cardiocirculatory effects of patent ductus arteriosus in extremely low‐birth‐weight infants with respiratory distress syndrome , 2003, Pediatrics international : official journal of the Japan Pediatric Society.

[48]  P. Steer,et al.  Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. , 2003, The Cochrane database of systematic reviews.

[49]  M. Mirochnick,et al.  Neonatal Necrotizing Enterocolitis With Intestinal Perforation in Extremely Premature Infants Receiving Early Indomethacin Treatment for Patent Ductus Arteriosus , 2002, Journal of Perinatology.

[50]  B. Schmidt,et al.  Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. , 2001, The New England journal of medicine.

[51]  J. Weyler,et al.  Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. , 2001, The Journal of pediatrics.

[52]  D B Knight,et al.  The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. , 2001, Seminars in neonatology : SN.

[53]  Y. Weng,et al.  Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment , 2001, Journal of perinatal medicine.

[54]  M. Kluckow,et al.  Superior vena cava flow in newborn infants: a novel marker of systemic blood flow , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[55]  M. Kluckow,et al.  Low superior vena cava flow and intraventricular haemorrhage in preterm infants , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[56]  T. O'Shea,et al.  Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants , 1999 .

[57]  B. Yoder,et al.  Neonatal chronic lung disease in extremely immature baboons. , 1999, American journal of respiratory and critical care medicine.

[58]  J. Skinner,et al.  Haemodynamic effects of altering arterial oxygen saturation in preterm infants with respiratory failure , 1999, Archives of disease in childhood. Fetal and neonatal edition.

[59]  N. Evans,et al.  Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. , 1996, Archives of disease in childhood. Fetal and neonatal edition.

[60]  M. Chaet,et al.  Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. , 1996, Annals of surgery.

[61]  R. Clyman,et al.  Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. , 1996, The Journal of pediatrics.

[62]  N. Evans,et al.  Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. , 1995, Archives of disease in childhood. Fetal and neonatal edition.

[63]  J. Garland,et al.  Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. , 1994, Pediatrics.

[64]  T. Fujiwara,et al.  Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. , 1994, The Journal of pediatrics.

[65]  M. Fejgin,et al.  Isolated Small Bowel Perforation Following Intrauterine Treatment with Indomethacin , 1994, American journal of perinatology.

[66]  N. Evans,et al.  Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. , 1994, Archives of disease in childhood. Fetal and neonatal edition.

[67]  T. Trus,et al.  Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. , 1993, Journal of pediatric surgery.

[68]  I. Booth,et al.  Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. , 1990, Archives of disease in childhood.

[69]  D. Delpy,et al.  Effects of indomethacin on cerebral haemodynamics in very preterm infants , 1990, The Lancet.

[70]  G. Cassady,et al.  A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. , 1989, The New England journal of medicine.

[71]  M. Heymann,et al.  Cardiovascular effects of patent ductus arteriosus in preterm lambs with respiratory distress. , 1987, Jornal de Pediatria.

[72]  R. Julian,et al.  Functional scoliosis as a long-term complication of surgical ligation for patent ductus arteriosus in premature infants. , 1986, Journal of pediatric surgery.

[73]  W. Rascher,et al.  Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. , 1983, The Journal of pediatrics.

[74]  J. Brady,et al.  Abnormal cerebral blood flow patterns in preterm infants with a large patent ductus arteriosus. , 1982, The Journal of pediatrics.

[75]  B. Armstrong,et al.  Continuous wave Doppler ultrasonographic quantitation of patent ductus arteriosus flow. , 1982, The Journal of pediatrics.

[76]  R. Wolfe,et al.  ST depression suggesting subendocardial ischemia in neonates with respiratory distress syndrome and patent ductus arteriosus. , 1979, The Journal of pediatrics.

[77]  M. J. Maisels,et al.  Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants. , 1978, The Journal of pediatrics.

[78]  W. Friedman,et al.  Pharmacologic closure of patent ductus arteriosus in the premature infant. , 1976, The New England journal of medicine.

[79]  N. Silverman,et al.  Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. , 1976, The New England journal of medicine.

[80]  P. McNamara,et al.  Staging the ductus arteriosus facilitates identification of neonates at increased risk of respiratory morbidity , 2011 .

[81]  P. Mandhan,et al.  Surgical closure of patent ductus arteriosus in preterm low birth weight infants. , 2009, Congenital heart disease.

[82]  W. Clement,et al.  Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants. , 2008, Archives of otolaryngology--head & neck surgery.

[83]  J. Skinner,et al.  Does Retrograde Diastolic Flow in the Descending Aorta Signify Impaired Systemic Perfusion in Preterm Infants? , 2008, Pediatric Research.